KEFLIN IN PLASTIC CONTAINER Drug Patent Profile
✉ Email this page to a colleague
When do Keflin In Plastic Container patents expire, and what generic alternatives are available?
Keflin In Plastic Container is a drug marketed by Lilly and is included in one NDA.
The generic ingredient in KEFLIN IN PLASTIC CONTAINER is cephalothin sodium. There are seven drug master file entries for this compound. Additional details are available on the cephalothin sodium profile page.
Summary for KEFLIN IN PLASTIC CONTAINER
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 72 |
Patent Applications: | 1,064 |
Formulation / Manufacturing: | see details |
DailyMed Link: | KEFLIN IN PLASTIC CONTAINER at DailyMed |
US Patents and Regulatory Information for KEFLIN IN PLASTIC CONTAINER
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lilly | KEFLIN IN PLASTIC CONTAINER | cephalothin sodium | INJECTABLE;INJECTION | 062549-001 | Sep 10, 1985 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Lilly | KEFLIN IN PLASTIC CONTAINER | cephalothin sodium | INJECTABLE;INJECTION | 062549-002 | Sep 10, 1985 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |